Fiscal Year (FY) 2024 Notice of Supplemental Funding Opportunity
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting administrative supplements in scope of the parent award for the five eligible grant recipients funded in FY22 and FY23 under the Grants to Prevent Prescription Drug/Opioid Overdose Program (PDO), Notice of Funding Opportunity (NOFO) SP-21-002. Recipients may receive up to $279,266 each for a total of $1,396,330 across the program. These recipients have a project end date for use of these supplemental funds of September 29, 2025. The supplemental funding will be used to fund a comprehensive Training of Trainer (ToT) model to enhance workforce development and capacity in the arena of preventing prescription drug/ overdose related deaths and adverse events within existing projects funded under the PDO program.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 165 (Monday, August 26, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 165 (Monday, August 26, 2024)]
[Notices]
[Pages 68452-68453]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-18943]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Fiscal Year (FY) 2024 Notice of Supplemental Funding Opportunity
AGENCY: Substance Abuse and Mental Health Services Administration,
Department of Health and Human Services (HHS).
ACTION: Notice of intent to award supplemental funding.
-----------------------------------------------------------------------
SUMMARY: This notice is to inform the public that the Substance Abuse
and Mental Health Services Administration (SAMHSA) is supporting
administrative supplements in scope of the parent award for the five
eligible grant recipients funded in FY22 and FY23 under the Grants to
Prevent Prescription Drug/Opioid Overdose Program (PDO), Notice of
Funding Opportunity (NOFO) SP-21-002. Recipients may receive up to
$279,266 each for a total of $1,396,330 across the program. These
recipients have a project end date for use of these supplemental funds
of September 29, 2025. The supplemental funding will be used to fund a
comprehensive Training of Trainer (ToT) model to enhance workforce
development and capacity in the arena of preventing prescription drug/
overdose related deaths and adverse
[[Page 68453]]
events within existing projects funded under the PDO program.
FOR FURTHER INFORMATION CONTACT: Shannon Hastings, NOFO Lead, Division
of Targeted Prevention, Center for Substance Abuse Prevention,
Substance Abuse and Mental Health Services Administration, 5600 Fishers
Lane, Rockville, MD 20857, email: <a href="/cdn-cgi/l/email-protection#de9a8a8ef3909198919eadbfb3b6adbff0b6b6adf0b9b1a8"><span class="__cf_email__" data-cfemail="0c48585c2142434a434c7f6d61647f6d2264647f226b637a">[email protected]</span></a>, telephone:
(240) 276-1869.
SUPPLEMENTARY INFORMATION:
Funding Opportunity Title: FY 2021 Grants to Prevent Prescription
Drug/Opioid Overdose-Related Deaths (PDO) SP-21-002.
Assistance Listing Number: 93.243.
Authority: Section 516 of the Public Health Service Act, as
amended, 42 U.S.C. 290bb-22.
Justification: These supplement awards will be offered to the FY22
and FY23 cohorts under SP-21-002. Supplemental funding will be awarded
to these cohorts because they have over three years remaining in their
awards to implement their projects. The cohorts, which are comprised of
state grantees, will receive a larger supplemental award per recipient
which will increase opportunity to implement the activities. These
cohorts have implemented existing activities well positioned to be
leveraged under the ToT model. These factors will benefit SAMHSA so
that the agency will be able to track the effects of the ToT model over
time. This work aligns with SAMHSA's goals of expanding access to
naloxone and other opioid overdose reversal medications and enhances
SAMHSA's naloxone saturation and overdose prevention efforts.
This is not a formal request for application. Assistance will only
be provided to the 5 PDO grant recipients funded in FY22 and FY23 under
the Grants to Prevent Prescription Drug/Opioid Overdose Program, NOFO
(SP-21-002) based on the receipt of a satisfactory application and
associated budget that is approved by a review group.
Dated: August 20, 2024.
Ann Ferrero,
Public Health Analyst.
[FR Doc. 2024-18943 Filed 8-23-24; 8:45 am]
BILLING CODE 4162-20-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.